pubmed-article:20945502 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0007600 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0014597 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0033572 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C1523298 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C2826170 | lld:lifeskim |
pubmed-article:20945502 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
pubmed-article:20945502 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:20945502 | pubmed:dateCreated | 2011-3-7 | lld:pubmed |
pubmed-article:20945502 | pubmed:abstractText | The majority of established human prostate cancer cell lines are derived from metastatic lesions and are already tumorigenic in vivo, therefore immortalized normal prostate cell lines may provide a more relevant model to unveil the mechanisms associated with cancer progression and metastasis. | lld:pubmed |
pubmed-article:20945502 | pubmed:language | eng | lld:pubmed |
pubmed-article:20945502 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20945502 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20945502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20945502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20945502 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20945502 | pubmed:month | May | lld:pubmed |
pubmed-article:20945502 | pubmed:issn | 1097-0045 | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:HsiehJer-Tson... | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:ShayJerry WJW | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:PongRey-ChenR... | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:RajGanesh VGV | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:YangLinL | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:KabbaniWareef... | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:MarianCalin... | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:ZouYing SYS | lld:pubmed |
pubmed-article:20945502 | pubmed:author | pubmed-author:GoreCrystalC | lld:pubmed |
pubmed-article:20945502 | pubmed:copyrightInfo | Copyright © 2010 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:20945502 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20945502 | pubmed:volume | 71 | lld:pubmed |
pubmed-article:20945502 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20945502 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20945502 | pubmed:pagination | 626-36 | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:meshHeading | pubmed-meshheading:20945502... | lld:pubmed |
pubmed-article:20945502 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:20945502 | pubmed:articleTitle | Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line. | lld:pubmed |
pubmed-article:20945502 | pubmed:affiliation | Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. | lld:pubmed |
pubmed-article:20945502 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20945502 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |